
How do I stay healthy in my 50s, 60s and 70s?
Here's what you need to know to extend the quality of life in these decades.
Entering midlife, a person's health needs can begin to change.
Sometimes these changes can be challenging, but there is 'plasticity to ageing', says Nathan LeBrasseur, director of the Mayo Clinic's Robert and Arlene Kogod Center on Aging, and you do have some control over the process.
What are normal signs of ageing and how does your body change in your 50s? Wear and tear on the body's cells and molecules increases the risk of ageing-related diseases, says LeBrasseur.
Biological age is a measure of these cellular and molecular changes over time. It captures how old your body appears based on biomarkers, like telomere length, and how well your body is functioning.
Biological age is a better measure of healthspan, or years of generally good health, than chronological age, or how many years you've been alive.
Lifestyle factors, like if you smoke or drink, influence how you age – and focusing on your health now will help in the future.
For some, the menopausal transition may begin between the ages of 45 and 55 and is linked to symptoms including hot flashes, mood changes and sleep disturbances. Women may also experience vaginal dryness or decreased sex drive, while men may begin to experience erectile dysfunction.
What health tests should you get regularly in your 50s? To extend your healthy years, take preventive and proactive measures. The American Cancer Society (ACS) recommends an annual skin cancer screening for anyone over 40, and talking to a healthcare provider about colorectal cancer screenings, yearly mammograms, and lung and prostate cancer screenings.
In the UK, the NHS offers a free health check to people aged 40 to 70 without certain pre-existing conditions. It includes blood pressure and cholesterol tests, and checks your risk of health issues like diabetes and stroke. At 50, you're also eligible for NHS breast, bowel and cervical cancer screenings.
What are the keys to longevity? Heart health is vital, as is being mindful of your nutrition and exercise. A diet rich in plants, whole grains, healthy fats and lean meats can improve your health. A diversity of physical activity – focusing on endurance, cardio, flexibility and balance – is crucial. It's never too late to start, and what you do over many years will have a long-term impact, says LeBrasseur.
Your 60s are a period of change. For many, this decade is marked by shifting family dynamics with adult children or new health challenges.
What are normal signs of ageing and how does your body change in your 60s? Getting older, and the physical changes that accompany it, vary person to person. 'We're all more vulnerable to things as we get older, but there's a lot of heterogeneity of health status among older people,' says Jennifer Schrack, director of the Johns Hopkins Center on Aging and Health.
Older adults may walk more slowly because of pain or emerging balance problems, says Schrack, and osteoarthritis symptoms causing discomfort may emerge as well. As the body ages, the immune system weakens and the risk factor for age-related diseases increases since the body takes longer to fight off infection.
Memory tends to change, and forgetfulness is common as you age, explains Dr Angela Sanford, a care provider and associate professor of geriatric medicine at St Louis University. It's common to see processing speed slow, and for multitasking to become a bigger challenge. If you worry about forgetfulness, a doctor can advise on cognitive screening tests.
In your 60s, sleep may become more disrupted, with studies indicating that 40 to 50% of those over 60 report difficulty sleeping.
What health tests should you get regularly in your 60s? People in their 60s should be mindful to have regular bloodwork done, says Sanford. An annual eye exam, screening for colorectal cancer and diabetes, are also recommended. Women should have mammograms and test bone density, which declines during menopause.
Sign up to Well Actually
Practical advice, expert insights and answers to your questions about how to live a good life
after newsletter promotion
What are the keys to longevity? Genetics, lifestyle choices and environment are the factors that most affect your health, says Schrack.
Regular appointments with a healthcare provider benefit all older people, Schrack says, and preventive care can improve longevity. Mobility and staying active contribute to quality of life as does maintaining positive relationships.
Today's septuagenarians are different. 'Many transitions that are happening now at 70 are the types of transitions people in previous generations might have experienced in their early 60s,' says Jeffrey Stokes, an associate professor at the University of Massachusetts Boston who studies ageing. People in this age group now have longer life expectancy, and are also becoming grandparents and retiring later than previous generations.
What are normal signs of ageing and how does your body change in your 70s? Some medical conditions and functional problems, like decreased mobility and impaired balance, become more common as people age, according to Dr Mark Lachs, chief of geriatrics and palliative medicine at Weill Cornell Medicine.
However, lifestyle factors play a role, and how much you feel these changes will be very individualized. And while there is no one 'normal' way to age, it is common to experience health challenges like arthritis, hypertension or increased trouble sleeping.
In comparison to earlier decades, your 70s can be quite stable – especially for women who have already experienced menopause.
What health tests should you get regularly in your 70s? Many recommended screenings are framed as guidelines for those above 65 in the US and UK. This reflects a lack of research and that screenings become more complicated as we age, says Dr Deborah Kado, a professor of medicine and co-director of the Stanford Longevity Center. It can be difficult to provide general recommendations because individual needs at this stage can vary.
Some screenings to consider are for bone mineral density and functional limitations (to see, if for example, you are at risk for falling), according to Dr Mark Lachs, chief of geriatrics and palliative medicine at Weill Cornell Medicine.
What are the keys to longevity? Movement is important, says Lachs, and any kind of cardiovascular exercise at modest levels will help. Relationships, both casual and close, can improve a person's health and sense of purpose, says Stokes.
While many people in their 70s will have deep, meaningful relationships – like those with children and grandchildren – there's often less emphasis on fostering new connections. Targeting this can help improve the loneliness and isolation faced by many in their oldest years, says Stokes.
Adequate sleep – at least seven to nine hours each night – and a diet that contains less meat and more plans can contribute to overall longevity, too.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
8 minutes ago
- The Independent
Hundreds more may have died in LA's devastating fires in January than first reported, study finds
The death toll from the devastating early January wildfires around Los Angeles may be more than 400 people greater than the official tally, according to a new study. The paper, published by Finnish researchers in an American Medical Association journal, looked at the difference between expected and observed deaths in Los Angeles County as the fires were burning and found 440 excess deaths. They attribute the excess deaths to health conditions made worse by wildfire smoke, as well as mental health issues and health interrupted by the blazes, among other factors. 'The findings from this study underscore the need to complement direct fatalities estimates with alternative methods to quantify the additional mortality burden of wildfires and of climate-related emergencies more broadly,' the authors wrote. 'They also highlight the need for improved mortality surveillance during and after wildfire emergencies.' The study got the attention local leaders, who are still rebuilding after the Palisades and Eatons fires destroyed more than 16,000 structures and were attributed directly to 31 deaths. L.A. County Supervisor Kathryn Barger, whose district includes the hard-hit Altadena area, said she had seen the study's findings with interest. 'This study's assertion that over 400 excess deaths are a result of our Los Angeles wildfires is concerning,' she told the local Daily Breeze newspaper. 'In response, I've asked our county's Department of Public Health to thoroughly review the findings and provide their input. It is critical that we understand the full scope of the wildfires' impacts.' Another group of recent studies looked at similar indirect impacts from the 2023 Maui wildfire. The Maui fire was directly blamed for more than 100 deaths. But it also left 1 in 5 with lung damage and as many as half with symptoms of depression, one set of new research found. The month of the fire saw 13 suicide and overdose deaths, translating to nearly double the normal suicide and overdose death rates. Jonathan Purtle of New York University was the lead author of one study, which calculated rates of suicide and overdose deaths in Maui and Hawaii's four other counties. That research team found a 97% increase in suicides and overdose death rates on Maui during the month of the wildfires. The total number of suicide and overdose deaths was 13 that month — most of them suicides. They also found a 46% increase in such deaths in all five counties, which may have been influenced by displaced Maui residents migrating to other islands, the authors said. The increases did not last: Rates fells in the following months, the researchers found.


The Independent
38 minutes ago
- The Independent
Study reveals health risks of excessive screen time in teens
Excessive screen time in children and young adults significantly increases the risk of heart-related health conditions such as high blood pressure, high cholesterol, and insulin resistance. Danish researchers found that this link is particularly strong in individuals who experience reduced sleep, suggesting screen use may be displacing crucial sleep time. The study, involving over 1,000 Danish youths, revealed that each additional hour of screen time daily worsened cardiometabolic risk, with three extra hours leading to a notable increase. Machine learning identified a 'screen-time fingerprint' in blood samples, indicating biological changes that could signal long-term heart health risks from early screen habits. Experts recommend gradually reducing screen time, particularly by shifting screen use earlier in the day and prioritizing earlier and longer sleep, to mitigate these health risks.


The Guardian
an hour ago
- The Guardian
Sales of Novo Nordisk's diabetes drugs including Ozempic slow sharply
Sales of Novo Nordisk's injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus. The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe's most valuable company, has lost nearly $100bn (£75bn) in market value since cutting its full-year sales forecast last week, when its share price slid 30% in its worst week in more than two decades. It fell a further 3% on Wednesday. On Wednesday, Novo Nordisk said sales of medications such as Ozempic – which mimic the GLP-1 gut hormone that regulates blood sugar levels and appetite – grew by 8% in the first half of the year, down from 21% last year. Sales of obesity drugs including Wegovy increased by 56%, taking total sales 16% higher to 155bn Danish kroner (£18bn). Profit before tax climbed by 24% to 70.8bn kroner. The company has lost market share to its US rival Eli Lilly's Mounjaro, which studies have shown to be more effective, as well as cheaper versions made by generic drugmakers. It has also been hit by 'compounding' in the US, where pharmacies make up medications from ingredients, even though the US regulator declared an end to the practice recently. Novo Nordisk's outgoing chief executive, Lars Fruergaard Jørgensen, said that the copycat market had 'equal size to our business' and that compounded versions of Wegovy were sold at a 'much lower price point'. Its finance chief, Karsten Munk Knudsen, said the company was pursuing various strategies, including lawsuits against compounding pharmacies and expanding its US direct-to-consumer platform, NovoCare, launched in March. The company might also pursue 'cash sales' directly to patients elsewhere. Jørgensen said Novo Nordisk was taking measures to 'sharpen our commercial execution further, and ensure efficiencies in our cost base while continuing to invest in future growth'. He said it would probably not be able to avoid layoffs, but that no decision had been made. He said it would be up to Maziar Mike Doustdar, who takes over as CEO on Thursday, to make such a decision. The company is now expecting sales growth of between 8% and 14% at constant exchange rates in 2025, down sharply from its previous estimate of 13% to 21%. Novo Nordisk also disclosed that it had ditched several weight-loss drugs in development, including one that has just completed an intermediate (phase II) clinical study, 'due to portfolio considerations'. The company faces a class action lawsuit in the US from investors, who claim that it misled them with optimistic growth forecasts in the lucrative weight loss market. The UBS analyst Matthew Weston said: 'We expect GLP-1 compounders to remain in the US, which limits cash-pay uptake and leaves an uncertain outlook for US Wegovy. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion 'President Trump's proposal to reimburse GLP-1 obesity in Medicare could add significant volume uplift, but most-favoured-nation demands to offer US cash sales at European prices could significantly reduce value.' Derren Nathan, the head of equity research at Hargreaves Lansdown, said: 'Tariffs and drug pricing policy are another threat Mike Doustdar will need to tackle head-on if one of Denmark's greatest success stories is to regain its crown as Europe's most valuable company. 'The 15% blanket rate on EU imports is not necessarily the end of the story as Donald Trump dangles the prospect of levies of up to 250% on pharmaceutical imports under a separate section 232 investigation.'